Patents by Inventor Yanyan XIE

Yanyan XIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11946349
    Abstract: A downhole throttling device based on wireless control includes an inlet nozzle, a throttling assembly, an electrical sealing cylinder, a gas guide cylinder, a lower adapter sleeve, an end socket, a female sleeve, and electrical components. The inlet nozzle is connected to the throttling assembly, the throttling assembly is connected to the electrical sealing cylinder and the gas guide cylinder, the electrical sealing cylinder and the gas guide cylinder are both connected to the lower adapter sleeve, the lower adapter sleeve is respectively connected to the end socket and the female sleeve, and the electrical components are arranged in the electrical sealing cylinder. A throttling effect is achieved by detecting the temperature and pressure in a tube by a temperature/pressure sensor in the electrical components and controlling a motor to rotate a movable valve in the throttling assembly by a circuit control assembly, thereby achieving wireless control over downhole throttling.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: April 2, 2024
    Assignees: PetroChina Company Limited, Sichuan Shengnuo Oil. And Gas Engineering Technology Service Co., Ltd
    Inventors: Jun Xie, Huiyun Ma, Jian Yang, Chenggang Yu, Yukun Fu, Qiang Yin, Kui Li, Yuan Jiang, Dezheng Yi, Yanyan Liu, Haifeng Zhong, Xiaodong Liu
  • Patent number: 11542474
    Abstract: The present invention provides a recombinant adipose-derived stem cell and a recombinant method thereof, and belongs to the technical field of genetic engineering, where an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell to obtain the recombinant adipose-derived stem cell. In the present invention, an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell, and the recombinant adipose-derived stem cell obtained after the transfection can express an hFIX protein.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: January 3, 2023
    Assignee: North China University of Science and Technology
    Inventors: Zhenyu Yan, Linhong Wang, Yanyan Xie, Xin Wang
  • Publication number: 20210015966
    Abstract: The disclosure provides a preparation method for a novel biocompatible antibacterial bacterial cellulose Fmoc-F hydrogel, belonging to the technical field of biomedical gels. The preparation method is characterized by comprising the following steps of (1) preparing a bacterial cellulose (BC) homogenate, (2) mixing the bacterial cellulose with an Fmoc-F solution, and preparing the bacterial cellulose/Fmoc-F antibacterial hydrogel by means of in-situ chemical crosslinking. The preparation method has the advantages of rapid gelling reaction, simple reaction system, high gel plasticity and the like. Because of the bacterial cellulose, the antibacterial hydrogel prepared in the disclosure has high mechanical strength. Meanwhile, compared with traditional micro-molecular antibacterial materials, the bacterial cellulose/Fmoc-F antibacterial hydrogels prepared in the disclosure have broad-spectrum antibacterial effects and good biocompatibility.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 21, 2021
    Inventors: Cheng ZHONG, Xiangjun Zhao, Yanwen Zhang, Fazli WAHID, Yanyan Xie, Shiru Jia
  • Publication number: 20200370019
    Abstract: The present invention provides a recombinant adipose-derived stem cell expressing a BDDhFVIII gene, and a preparation method and application thereof, and belongs to the technical field of genetically engineered drugs. The recombinant adipose-derived stem cell is obtained by infecting an adipose-derived stem cell with an adenoviral vector expressing the BDDhFVIII gene. The preparation method includes the following steps: constructing an adenoviral vector expressing a BDDhFVIII gene; extracting an adipose-derived stem cell; and infecting the adipose-derived cell with the adenoviral vector expressing the BDDhFVIII gene to obtain the recombinant adipose-derived stem cell. The recombinant adipose-derived stem cell can express the blood coagulation factor VIII safely and persistently, and have a high application prospect for treating the hemophilia A.
    Type: Application
    Filed: November 18, 2019
    Publication date: November 26, 2020
    Inventors: Zhenyu YAN, Yanyan XIE, Linhong WANG, Yiwen ZHU
  • Publication number: 20200362311
    Abstract: The present invention provides a recombinant adipose-derived stem cell and a recombinant method thereof, and belongs to the technical field of genetic engineering, where an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell to obtain the recombinant adipose-derived stem cell. In the present invention, an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell, and the recombinant adipose-derived stem cell obtained after the transfection can express an hFIX protein.
    Type: Application
    Filed: October 30, 2019
    Publication date: November 19, 2020
    Inventors: Zhenyu YAN, Linhong WANG, Yanyan XIE, Xin WANG